SCHEMBL34332

SCHEMBL34332

O=[C]C(C/[C]=N/O)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17457457 0.68
SCHEMBL9762888 0.67
SCHEMBL20876138 0.67
SCHEMBL284721 0.64
SCHEMBL4382677 0.64
SCHEMBL6035007 0.56
SCHEMBL6284528 0.56
Sulfuric Acid SCHEMBL28320528 0.53
SCHEMBL7045868 0.52
SCHEMBL28950975 0.52 SLC22A6 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197899-A1 2-AMINO-4-CARBOXAMIDE-BENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2024-06-20 US claimed
US-20230349917-A1 NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES AMBERGEN, INC. 2023-11-02 US claimed
US-20230293716-A1 ELASTASE-SUBSTRATE, PEPTIDE LINKER IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2023-09-21 US claimed
US-11654199-B2 Thienoazepine immunoconjugates, and uses thereof BOLT BIOTHERAPEUTICS, INC. (US) 2023-05-23 US claimed
WO-2023018199-A1 NOVEL ANTIBIOTIC AND USE THEREOF 주식회사 레고켐바이오사이언스 2023-02-16 WO claimed
US-20210128744-A1 THIENOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2021-05-06 US claimed
US-20200390899-A1 AMINOBENZAZEPINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2020-12-17 US claimed
US-20190216940-A1 Prodrugs Comprising a Pyroglutamate Linker ASCENDIS PHARMA A/S (DK) 2019-07-18 US claimed
EP-2889624-B1 Reversible covalent linkage of functional molecules UCL BUSINESS PLC (GB) 2018-10-03 EP claimed
EP-3303365-A2 PRODRUGS COMPRISING A PYROGLUTAMATE LINKER Ascendis Pharma Inc. (US) 2018-04-11 EP claimed
EP-0665729-B1 BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC MOIETIES GEN HOSPITAL CORP (US) 2003-05-07 EP claimed
EP-0923287-A4 NONCLASSICAL PYRROLO 2,3-D]PYRIMIDINE ANTIFOLATES LILLY CO ELI (US) 2001-08-01 EP claimed
EP-0923287-A1 NONCLASSICAL PYRROLO 2,3-D]PYRIMIDINE ANTIFOLATES ELI LILLY AND COMPANY (US) 1999-06-23 EP claimed
US-5871710-A BIOCOMPATABLE PLATINUM ADDUCT WITH POLYMER THE GENERAL HOSPITAL CORPORATION (US) 1999-02-16 US claimed
WO-1998008382-A1 NONCLASSICAL PYRROLO[2,3-D]PYRIMIDINE ANTIFOLATES ELI LILLY AND COMPANY (US) 1998-03-05 WO claimed
WO-1996000079-A1 GRAFT CO-POLYMER ADDUCTS OF PLATINUM (II) COMPOUNDS THE GENERAL HOSPITAL CORPORATION (US) 1996-01-04 WO claimed
EP-0665729-A4 BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC MOIETIES. GEN HOSPITAL CORP (US) 1995-11-29 EP claimed
EP-0665729-A1 BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC MOIETIES THE GENERAL HOSPITAL CORPORATION (US) 1995-08-09 EP claimed
WO-1994005203-A1 BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC MOIETIES THE GENERAL HOSPITAL CORPORATION (US) 1994-03-17 WO claimed
WO-1988008875-A1 CYCLING BIOCHIP SENSOR THE WASHINGTON TECHNOLOGY CENTER (US) 1988-11-17 WO claimed